JP2024540483A5 - - Google Patents

Info

Publication number
JP2024540483A5
JP2024540483A5 JP2024529341A JP2024529341A JP2024540483A5 JP 2024540483 A5 JP2024540483 A5 JP 2024540483A5 JP 2024529341 A JP2024529341 A JP 2024529341A JP 2024529341 A JP2024529341 A JP 2024529341A JP 2024540483 A5 JP2024540483 A5 JP 2024540483A5
Authority
JP
Japan
Application number
JP2024529341A
Other languages
Japanese (ja)
Other versions
JP2024540483A (ja
JPWO2023092107A5 (https=
Filing date
Publication date
Priority claimed from PCT/US2022/080165 external-priority patent/WO2023092088A1/en
Application filed filed Critical
Publication of JP2024540483A publication Critical patent/JP2024540483A/ja
Publication of JP2024540483A5 publication Critical patent/JP2024540483A5/ja
Publication of JPWO2023092107A5 publication Critical patent/JPWO2023092107A5/ja
Pending legal-status Critical Current

Links

JP2024529341A 2021-11-19 2022-11-19 Ｃｄｋ２阻害剤及びその製造方法及び使用方法 Pending JP2024540483A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163281508P 2021-11-19 2021-11-19
US63/281,508 2021-11-19
USPCT/US2022/080165 2022-11-18
PCT/US2022/080165 WO2023092088A1 (en) 2021-11-19 2022-11-18 Cdk2 inhibitors and methods of making and using same
PCT/US2022/080199 WO2023092107A1 (en) 2021-11-19 2022-11-19 Cdk2 inhibitors and methods of making and using same

Publications (3)

Publication Number Publication Date
JP2024540483A JP2024540483A (ja) 2024-10-31
JP2024540483A5 true JP2024540483A5 (https=) 2025-11-27
JPWO2023092107A5 JPWO2023092107A5 (https=) 2025-11-27

Family

ID=84901264

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024529341A Pending JP2024540483A (ja) 2021-11-19 2022-11-19 Ｃｄｋ２阻害剤及びその製造方法及び使用方法

Country Status (5)

Country Link
US (1) US20250074895A1 (https=)
EP (1) EP4433470A1 (https=)
JP (1) JP2024540483A (https=)
CN (1) CN118265706A (https=)
WO (2) WO2023092088A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022271290A1 (en) 2021-05-07 2023-11-23 Kymera Therapeutics, Inc. Cdk2 degraders and uses thereof
US11932648B2 (en) 2021-06-28 2024-03-19 Blueprint Medicines Corporation CDK2 inhibitors
CN119072471A (zh) * 2022-04-28 2024-12-03 正大天晴药业集团股份有限公司 一种吡唑取代环戊酯衍生物及其用途
CN120239698A (zh) * 2022-11-17 2025-07-01 山东绿叶制药有限公司 Cdk2抑制剂及其制备方法和应用
US20240317777A1 (en) * 2023-02-23 2024-09-26 Accutar Biotechnology Inc. Novel macrocyclic aminopyrazole compounds as cdk2 inhibitors
WO2025062334A1 (en) * 2023-09-20 2025-03-27 Beigene Switzerland Gmbh 4-((5-(3-(4-(pyridin-2-yl)cyclopentyl)-1 h-pyrazol-3-yl)amino)-benzenesulfonamide derivatives and similar compounds as cdk inhibitors for the treatment of cancer
WO2026024674A1 (en) 2024-07-22 2026-01-29 Genesis Therapeutics, Inc. Methods of treating skp2-associated cancers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL154016A0 (en) * 2000-08-31 2003-07-31 Pfizer Prod Inc Pyrazole derivatives and their use as protein kinase inhibitors
WO2020050653A1 (ko) 2018-09-05 2020-03-12 삼성전자 주식회사 이동 통신 시스템에서 papr 감소를 위한 기준 신호 시퀀스 생성 방법 및 장치
CN113330000B (zh) * 2019-01-31 2024-12-24 辉瑞公司 具有对cdk2的抑制活性的3-羰基氨基-5-环戊基-1fi-吡咯化合物

Similar Documents

Publication Publication Date Title
JP2024538694A5 (https=)
CL2025003870A1 (es) Compuestos para el suministro de granulina a través de la barrera hematoencefálica.
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13149U (https=)
BY13159U (https=)
BY13140U (https=)
BY13141U (https=)
BY13142U (https=)
BY13143U (https=)
BY13144U (https=)
BY13145U (https=)
BY13135U (https=)